It was obvious that the phenotypes displayed by Ocn−/− mice were similar to that of clinical T2DM, and the beneficial effects on energy metabolism through exogenous administration of OCN in both cellular and rodent models potentiate its therapeutic possibilities in T2DM and other related metabolic diseases. This evidence concerns the gene BGLAP and metabolic disease.